Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
1.750
-0.060 (-3.31%)
At close: Jun 6, 2025, 4:00 PM
1.830
+0.080 (4.57%)
After-hours: Jun 6, 2025, 5:23 PM EDT
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $9.68 million as of June 6, 2025. Its market cap has decreased by -65.02% in one year.
Market Cap
9.68M
Enterprise Value
-9.60M
1-Year Change
-65.02%
Ranking
Category
Stock Price
$1.75
Market Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $9.68M, a decrease of -48.88%. That is a compound annual growth rate of -19.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 9.68M | -45.86% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 690.55B |
| Johnson & Johnson | 372.34B |
| AbbVie | 335.83B |
| Novo Nordisk | 332.47B |
| UnitedHealth Group | 273.58B |
| Abbott Laboratories | 232.56B |
| Novartis AG | 230.96B |
| AstraZeneca | 225.55B |